Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
ID: 359090Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359090
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of cancer epidemiology cohorts through the "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts" initiative. This cooperative agreement aims to address critical knowledge gaps in cancer etiology and survivorship by laying the groundwork for future studies that will explore various factors influencing cancer risk and outcomes. Eligible applicants for this discretionary grant include small businesses, with no cost-sharing or matching requirements. Interested parties should note that the estimated synopsis post date is August 1, 2025, and applications are due by November 5, 2025, with awards expected to be made by July 1, 2026. For further inquiries, contact Naoko Ishibe Simonds, Sc.D., or Lisa Gallicchio, Ph.D., at 240-276-6967 or via email at naoko.simonds@nih.gov.

    Point(s) of Contact
    Naoko Ishibe Simonds, Sc.D. and Lisa Gallicchio, Ph.D. National Cancer Institute (NCI)
    (240) 276-6967
    naoko.simonds@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for research in cancer epidemiology cohort studies through a Cooperative Agreement. This initiative aims to support hypothesis-based research that addresses critical knowledge gaps in cancer etiology and survivorship, including the maintenance of cohorts, continued follow-up, and the sharing of data and biospecimen resources. This funding is vital for advancing understanding in the field of cancer research, which can lead to improved outcomes for patients. Interested small businesses can reach out to Dr. Somdat Mahabir at mahabir@mail.nih.gov or call 240-276-6914 for more information. The estimated synopsis post date is August 1, 2025, with applications due by November 5, 2025, and awards expected to be made by July 1, 2026.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging diverse cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program anticipates awarding approximately $73 million across 50 grants, with applications from small businesses eligible, provided they are not affiliated with certain NCI-funded institutions. Interested applicants can reach out to Dr. Brandy Heckman-Stoddard at 240-276-7048 or via email at heckmanbm@mail.nih.gov for further information. The estimated synopsis will be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and awards expected to be made by August 1, 2026.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the NCI Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program will support seven awards with an estimated total funding of $60 million, and applications are open to small businesses. Interested applicants should note that the synopsis is expected to be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and the anticipated award date is August 1, 2026. For further inquiries, contact Brandy Heckman-Stoddard, Ph.D., M.P.H., at 240-276-7048 or via email at heckmanbm@mail.nih.gov.
    Opportunities for Collaborative Research at the NIH Clinical Center
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Opportunities for Collaborative Research at the NIH Clinical Center," aimed at supporting collaborative translational research projects that enhance the application of basic biological discoveries to clinical settings. This program encourages partnerships between NIH intramural investigators and extramural researchers to accelerate patient-centric translational research, focusing on understanding disease processes and developing new therapeutic interventions, diagnostics, or prevention strategies. Interested small businesses can apply for this cooperative agreement, with no cost-sharing requirement, and should note that the estimated synopsis post date is September 1, 2025, with a closing date of December 12, 2025. For further inquiries, applicants can contact Dr. David J. Eckstein at 301-496-4121 or via email at ClinicalCtrPartner@mail.nih.gov.
    Forecast to Publish a Funding Opportunity Announcement for the Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cancer Intervention and Surveillance Modeling Network (CISNET) under the U01 cooperative agreement mechanism, which will not allow clinical trials. This initiative aims to leverage simulation modeling to enhance the evidence derived from clinical trials, epidemiologic studies, and surveillance data, thereby informing public health research and priorities throughout the cancer continuum. The opportunity is particularly relevant for small businesses with expertise in comparative simulation modeling methods for cancer control, as well as collaborative teams that integrate knowledge from decision modeling, statistics, health economics, epidemiology, computer science, medicine, and public health. Interested applicants should prepare for the application process, with the estimated synopsis posting date set for July 31, 2025, and the application deadline anticipated for November 7, 2025. For further inquiries, potential applicants can contact Dr. Natasha Stout at natasha.stout@nih.gov or by phone at 240-478-8909.
    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)." This initiative encourages applications that propose innovative secondary data analyses and integration of existing datasets to address significant scientific questions related to cancer risk, prevention, and treatment outcomes. The program aims to leverage diverse data sources, including clinical, environmental, and genomic datasets, to enhance understanding of cancer and improve public health strategies. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and tribal governments, with a maximum funding amount of $200,000 and a project duration of up to two years. Interested parties can find more information and application details at the NIH grants website, with the submission deadline set for September 7, 2026.
    Forecast to Publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) aimed at NCI-designated Cancer Centers. This initiative invites applications from small businesses to support various types of Cancer Centers, including Comprehensive, Clinical, and Basic Cancer Centers, with the goal of enhancing cancer research capabilities and fostering collaboration across institutional boundaries. The CCSGs are crucial for advancing the understanding of cancer and developing effective prevention, diagnosis, and treatment strategies. Interested applicants can reach out to the Office of Cancer Centers at the National Cancer Institute via email at ncicenters-r@mail.nih.gov or by phone at 240-276-5600. The estimated synopsis will be posted on October 1, 2025, with applications closing on January 25, 2026, and awards expected to be made by December 1, 2026.
    Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)" aimed at fostering long-term partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs). This initiative seeks to enhance cancer research by addressing disparities in cancer outcomes and promoting outreach and engagement across diverse populations. The program anticipates awarding approximately 12 cooperative agreements, with a minimum funding amount of $850,000, and key deadlines include an estimated synopsis close date of January 16, 2026, and an expected award date of September 1, 2026. For further inquiries, interested applicants can contact Dr. Sandra San Miguel-Majors at 240-276-5977 or via email at ncicpachU54@mail.nih.gov.
    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a Notice of Funding Opportunity (NOFO) titled "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes" (PAR-23-254). This initiative aims to encourage researchers to conduct innovative analyses of existing datasets, including clinical, genomic, and epidemiological data, to address critical questions related to cancer risk, treatment responses, and health outcomes. By leveraging previously collected data, the program seeks to enhance understanding of cancer-related issues while allowing for a limited generation of new data for validation purposes. Eligible applicants include a wide range of institutions, with funding capped at $350,000 annually for up to five years. Applications will be accepted from October 2023 until June 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Exploratory Grants in Cancer Control through the R21 Clinical Trial Optional mechanism, aimed at advancing innovative research in cancer control. This funding opportunity encourages applications focused on behavioral modification, screening, and understanding the etiological factors of cancer, with the goal of developing novel methodologies and tools that can significantly impact population-based cancer research. Grants of up to $275,000 are available for projects lasting up to two years, with application deadlines beginning January 16, 2025, and continuing through 2028. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PA-25-253.html.